<?xml version="1.0" encoding="UTF-8"?>
<p>The encouraging results reported here merit further controlled clinical trials designed to test further safety and efficacy of intraputaminally grafted cell culture-manufactured undifferentiated NPCs to treat multiple deficiencies in PD.</p>
